Feature | May 20, 2013

Endovascular Repair Of Ruptured Aneurysms Saves More Lives Than Surgery

Ten-year study looks at 106 patients with abdominal aortic aneurysms.

May 20, 2013 — Patients with ruptured abdominal aortic aneurysms (AAA) are more than twice as likely to survive if they have minimally invasive repair than if they have surgery, suggests a 10-year study being.

The aorta is the body’s main artery and about 90 percent of people who suffer from ruptured AAAs bleed to death. Those who make it to the hospital undergo either open surgical repair or minimally invasive treatment with endovascular aneurysm repair (EVAR). 

“Many of these patients are frail, with a variety of health issues, and a minimally invasive solution is by far the best option,” said Sherif Sultan, M.B., M.D., an endovascular surgeon at the University College Hospital Galway, Ireland. “We found 85 percent of patients are suitable for minimally invasive aneurysm repair and in those patients, EVAR should always be the first option.”

The study involved 106 patients who had AAA repair between 2002 and 2012, 75 of whom had open surgery and 31 of whom had EVAR. Overall mortality was higher for surgery patients, with 49 (65 percent) dying within 30 days versus 10 (32 percent) of those who had EVAR. After one year, 12.5 percent of surgery patients were alive versus 56 percent of EVAR patients. Most of the patients died of a co-existing health condition.

AAA is a weakening and ballooning in the aorta, the artery that carries blood from the heart to the rest of the body. AAA is most common in men 65 years or older. Other risk factors include a history of smoking, high blood pressure, high cholesterol and atherosclerosis. The larger the AAA, the more likely it is to rupture. 

Open surgical repair of the aorta involves making a 12-inch incision in the chest and cracking open the ribs to access the aorta. The patient is placed on partial heart-lung bypass, the aorta is clamped off and a fabric graft sewn into place.

EVAR involves threading a collapsed fabric tube, or endograft, through a catheter into a small incision in the groin artery and advancing it through the artery to the site of the tear in the aorta. The endograft is expanded in place, and blood flow is redirected through it, sealing off the tear.

For more information: www.iset.org

Related Content

PFO occluder, amplatzer
Feature | Structural Heart Occluders| May 27, 2016 | Dave Fornell
May 27, 2016 — A U.S.
radial access, transradial
Feature | Radial Access| May 27, 2016 | Dave Fornell
The use of transradial artery vascular access for percutaneous coronary intervention (PCI) in the United States has s
Ambio Health telemonitoring system, LifeBridge Health Cardiovascular Institute, Baltimore, pilot study
News | Remote Monitoring| May 26, 2016
The LifeBridge Health Cardiovascular Institute, Baltimore, has launched a pilot study to evaluate the potential...
cath lab, radiation exposure, glocoma
Feature | Radiation Dose Management| May 26, 2016 | Dave Fornell
May 27, 2016 — Radiation exposure to cath lab staff and physicians has seen growing concern in recent years, as the p
Edwards, Sapien 3, SOURCE 3 Registry, EuroPCR 2016
News | Heart Valve Technology| May 24, 2016
Thirty-day data from the European post-approval study of the Edwards Sapien 3 transcatheter aortic heart valve...
News | Cath Lab| May 24, 2016
The Society for Cardiovascular Angiography and Interventions (SCAI) 2016 Scientific Sessions took place May 4-7, 2016
HeartFlow, FFR-CT, ruptured coronary plaques, EMERALD study, EuroPCR 2016
News | CT Angiography (CTA)| May 23, 2016
First-in-human data presented at EuroPCR 2016 demonstrate that hemodynamic data from HeartFlow Inc. may help predict...
TAVR outcomes, aortic valve gradient, JACC study
News | Heart Valve Technology| May 23, 2016
Patients with a combination of left ventricular dysfunction and low aortic valve gradient have higher mortality rates...
Direct Flow Medical, TAVR device, DISCOVER trial, three-year results, EuroPCR 2016
News | Heart Valve Technology| May 20, 2016
Direct Flow Medical Inc. presented three-year results from its prospective, multicenter DISCOVER Trial at the EuroPCR...
Bioventrix, Revivent-TC System, heart failure, first-in-man procedure
News | Heart Failure| May 19, 2016
BioVentrix announced the first-in-man use of its next-generation Revivent-TC System with an endovascular catheter-based...
Overlay Init